CoCo-PCOS - Comprehensive Health Effects of Combined Contraceptives: a 6-month randomized, controlled, open-label trial of E4+DRSP, EE20µg+DRSP, and DRSP-only in women with PCOS
Phase 4 – monitoring after market approval
Conditions:
Contraception
Sponsor: Pohjois-Pohjanmaan hyvinvointialue, University Of Oulu
trial.available_in:
БГ
Overview
Trial status: Authorised
6-month use of study preparation, endpoint visit
Who can participate
Age group: 18-64 years
Gender: Female
Target enrollment: 156 participants
БГ